FDA approval of lecanemab: the real start of widespread amyloid PET use? - the EANM Neuroimaging Committee perspective

被引:42
作者
Verger, Antoine [1 ,2 ,3 ]
Yakushev, Igor [4 ]
Albert, Nathalie L. [5 ]
van Berckel, Bart [6 ]
Brendel, Matthias [5 ]
Cecchin, Diego [7 ]
Fernandez, Pablo Aguiar [8 ,9 ]
Fraioli, Francesco [10 ]
Guedj, Eric [11 ]
Morbelli, Silvia [12 ]
Tolboom, Nelleke [13 ]
Traub-Weidinger, Tatjana [14 ]
Van Weehaeghe, Donatienne [15 ]
Barthel, Henryk [16 ]
机构
[1] Univ Lorraine, Dept Nucl Med, CHRU, Nancy, France
[2] Univ Lorraine, Nancyclotep Imaging Platform, CHRU, Nancy, France
[3] INSERM, U1254, IADI, Nancy, France
[4] Tech Univ Munich, Sch Med, Dept Nucl Med, Ismaninger Str 22, D-81675 Munich, Germany
[5] Ludwig Maximilians Univ Munchen, Dept Nucl Med, Munich, Germany
[6] Univ Med Ctr Utrecht, Dept Radiol & Nucl Med, Utrecht, Netherlands
[7] Univ Padua, Dept Med DIMED, Nucl Med Unit, Padua, Italy
[8] Univ Santiago de Compostela USC, Fac Med, Dept Radiol, Campus Vida, Santiago De Compostela, Galicia, Spain
[9] Univ Santiago de Compostela USC, Ctr Res Mol Med & Chron Dis CIMUS, Campus Vida, Santiago De Compostela, Galicia, Spain
[10] UCL, Inst Nucl Med, London, England
[11] Aix Marseille Univ, CNRS, Inst Fresnel,Nucl Med Dept, Timone Hosp,APHM,CERIMED,Cent Marseille, Marseille, France
[12] Univ Genoa, Dept Hlth Sci, Nucl Med Unit, Genoa, Italy
[13] Univ Med Ctr Groningen, Nucl Med & Mol Imaging, Groningen, Netherlands
[14] Med Univ Vienna, Div Nucl Med, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria
[15] Ghent Univ Hosp, Dept Radiol & Nucl Med, Ghent, Belgium
[16] Univ Leipzig, Dept Nucl Med, Leipzig, Germany
关键词
DEMENTIA;
D O I
10.1007/s00259-023-06177-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:1553 / 1555
页数:3
相关论文
共 20 条
[1]   Effects of monoclonal antibodies against amyloid-β on clinical and biomarker outcomes and adverse event risks: A systematic review and meta-analysis of phase III RCTs in Alzheimer's disease [J].
Avgerinos, Konstantinos, I ;
Ferrucci, Luigi ;
Kapogiannis, Dimitrios .
AGEING RESEARCH REVIEWS, 2021, 68
[2]   Glitter in the Darkness? Nonfibrillar β-Amyloid Plaque Components Significantly Impact the β-Amyloid PET Signal in Mouse Models of Alzheimer Disease [J].
Biechele, Gloria ;
Monasor, Laura Sebastian ;
Wind, Karin ;
Blume, Tanja ;
Parhizkar, Samira ;
Arzberger, Thomas ;
Sacher, Christian ;
Beyer, Leonie ;
Eckenweber, Florian ;
Gildehaus, Franz-Josef ;
Von Ungern-Sternberg, Barbara ;
Willem, Michael ;
Bartenstein, Peter ;
Cumming, Paul ;
Rominger, Axel ;
Herms, Jochen ;
Lichtenthaler, Stefan F. ;
Haass, Christian ;
Tahirovic, Sabina ;
Brendel, Matthias .
JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (01) :117-124
[3]   Added value of 18F-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study [J].
Ceccaldi, Mathieu ;
Jonveaux, Therese ;
Verger, Antoine ;
Krolak-Salmon, Pierre ;
Houzard, Claire ;
Godefroy, Olivier ;
Shields, Trevor ;
Perrotin, Audrey ;
Gismondi, Rossella ;
Bullich, Santiago ;
Jovalekic, Aleksandar ;
Raffa, Nicola ;
Pasquier, Florence ;
Semah, Franck ;
Dubois, Bruno ;
Habert, Marie-Odile ;
Wallon, David ;
Chastan, Mathieu ;
Payoux, Pierre ;
Stephens, Andrew ;
Guedj, Eric .
ALZHEIMERS & DEMENTIA, 2018, 14 (03) :293-305
[4]   Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias [J].
Chetelat, Gael ;
Arbizu, Javier ;
Barthel, Henryk ;
Garibotto, Valentina ;
Law, Ian ;
Morbelli, Silvia ;
van de Giessen, Elsmarieke ;
Agosta, Federica ;
Barkhof, Frederik ;
Brooks, David J. ;
Carrillo, Maria C. ;
Dubois, Bruno ;
Fjell, Anders M. ;
Frisoni, Giovanni B. ;
Hansson, Oskar ;
Herholz, Karl ;
Hutton, Brian F. ;
Jack, Clifford R., Jr. ;
Lammertsma, Adriaan A. ;
Landau, Susan M. ;
Minoshima, Satoshi ;
Nobili, Flavio ;
Nordberg, Agneta ;
Ossenkoppele, Rik ;
Oyen, Wim J. G. ;
Perani, Daniela ;
Rabinovici, Gil D. ;
Scheltens, Philip ;
Villemagne, Victor L. ;
Zetterberg, Henrik ;
Drzezga, Alexander .
LANCET NEUROLOGY, 2020, 19 (11) :951-962
[5]   Consistency of efficacy results across various clinical measures and statistical methods in the lecanemab phase 2 trial of early Alzheimer's disease [J].
Dhadda, Shobha ;
Kanekiyo, Michio ;
Li, David ;
Swanson, Chad J. ;
Irizarry, Michael ;
Berry, Scott ;
Kramer, Lynn D. ;
Berry, Donald A. .
ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
[6]   AMYPAD Diagnostic and Patient Management Study: Rationale and design [J].
Frisoni, Giovanni B. ;
Barkhof, Frederik ;
Altomare, Daniele ;
Berkhof, Johannes ;
Boccardi, Marina ;
Canzoneri, Elisa ;
Collij, Lyduine ;
Drzezga, Alexander ;
Farrar, Gill ;
Garibotto, Valentina ;
Gismondi, Rossella ;
Gispert, Juan-Domingo ;
Jessen, Frank ;
Kivipelto, Miia ;
Alves, Isadora Lopes ;
Luis Molinuevo, Jose ;
Nordberg, Agneta ;
Payoux, Pierre ;
Ritchie, Craig ;
Savicheva, Irina ;
Scheltens, Philip ;
Schmidt, Mark E. ;
Schott, Jonathan M. ;
Stephens, Andrew ;
van Berckel, Bart ;
Vellas, Bruno ;
Walker, Zuzana ;
Raffa, Nicola .
ALZHEIMERS & DEMENTIA, 2019, 15 (03) :388-399
[7]   The approval of a disease-modifying treatment for Alzheimer's disease: impact and consequences for the nuclear medicine community [J].
Garibotto, Valentina ;
Albert, Nathalie L. ;
Barthel, Henryk ;
van Berckel, Bart ;
Boellaard, Ronald ;
Brendel, Matthias ;
Cecchin, Diego ;
Ekmekcioglu, Ozgul ;
van de Giessen, Elsmarieke ;
Guedj, Eric ;
Lammerstma, Adriaan A. ;
Semah, Franck ;
Traub-Weidinger, Tatjana ;
Van Weehaeghe, Donatienne ;
Morbelli, Silvia .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (10) :3033-3036
[8]   Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease [J].
Honig, Lawrence S. ;
Vellas, Bruno ;
Woodward, Michael ;
Boada, Merce ;
Bullock, Roger ;
Borrie, Michael ;
Hager, Klaus ;
Andreasen, Niels ;
Scarpini, Elio ;
Liu-Seifert, Hong ;
Case, Michael ;
Dean, Robert A. ;
Hake, Ann ;
Sundell, Karen ;
Hoffmann, Vicki Poole ;
Carlson, Christopher ;
Khanna, Rashna ;
Mintun, Mark ;
DeMattos, Ronald ;
Selzler, Katherine J. ;
Siemers, Eric .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (04) :321-330
[9]   A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease [J].
Ostrowitzki, Susanne ;
Lasser, Robert A. ;
Dorflinger, Ernest ;
Scheltens, Philip ;
Barkhof, Frederik ;
Nikolcheva, Tania ;
Ashford, Elizabeth ;
Retout, Sylvie ;
Hofmann, Carsten ;
Delmar, Paul ;
Klein, Gregory ;
Andjelkovic, Mirjana ;
Dubois, Bruno ;
Boada, Merce ;
Blennow, Kaj ;
Santarelli, Luca ;
Fontoura, Paulo .
ALZHEIMERS RESEARCH & THERAPY, 2017, 9
[10]   A comparison of advanced semi-quantitative amyloid PET analysis methods [J].
Peira, Enrico ;
Poggiali, Davide ;
Pardini, Matteo ;
Barthel, Henryk ;
Sabri, Osama ;
Morbelli, Silvia ;
Cagnin, Annachiara ;
Chincarini, Andrea ;
Cecchin, Diego .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (12) :4097-4108